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Enterotoxigenic Escherichia coli (ETEC) is one of the most common causes of diarrhoea among
young children in developing countries. ETEC vaccines offer promise in reducing the burden of
ETEC disease, but the development of these vaccines relies on the characterization of ETEC
isolates from a variety of settings. To best reflect the full spectrum of ETEC disease in León,
Nicaragua, the aim of this study was to characterize ETEC strains isolated from children with
diarrhoea attending different settings (hospital, primary care clinics and in the community) and
children from different age groups. We characterized ETEC isolates in terms of their colonization
factors (CFs) and enterotoxins, and determined whether these factors varied with setting and age
group. Diarrhoeal stool samples were obtained from children under the age of 60 months from:
(1) the regional public hospital, (2) four public primary care clinics, and (3) a population-based
cohort. In total, 58 ETEC-positive isolates were analysed by multiplex-PCR assays for the
identification of CFs (CS1, CS2, CS3, CS4, CS5, CS6, CS7, CS8, CS12, CS13, CS14, CS15,
CS17, CS18, CS19, CS20, CS21, CS22 and CFA/I), and enterotoxins [heat-labile toxin (LT) and
heat-stable variants STh and STp]. The frequency of CFs and enterotoxins was compared among
the three settings and for different age groups, using Fisher’s exact test or a x2 test. At least one
CF was detected among one-half of samples; CS19 was detected among all strains in which a
CF was identified, either alone or in combination with another CF. Among all CFs detected,
91.7 % were identified as members of the class 5 fimbrial family. CFs were detected more
commonly among samples from infants captured in the health facility setting compared with the
community setting. Overall, LT was detected among 67.2 % of samples, STh was detected
among 20.7 % and both enterotoxins were detected among 12.1 %. The enterotoxin STh was
detected more commonly among cases in the community, whilst a combination of STh and LT was
detected more commonly among cases treated in health facilities. Our results suggest that, to
protect against diarrhoeal cases associated with this E. coli pathotype in León, Nicaragua, an
ETEC vaccine that effectively targets the archeotype CFA/I of the class 5 fimbrial family would be
the most effective in this setting.
INTRODUCTION
Enterotoxigenic Escherichia coli (ETEC) is one of the most
common causes of diarrhoea among young children in the
developing world (Qadri et al., 2007; Paniagua et al., 1997).
Each year, ETEC is responsible for an estimated 280
million diarrhoea episodes and 300 000–500 000 deaths
(Wennerås & Erling, 2004; World Health Organization,
2006). In Nicaragua, the different types of diarrhoeagenic
E. coli have been investigated. However, ETEC and entero-
haemorrhagic E. coli have been the only types statistically
associated with diarrhoea among young children (Paniagua
et al., 1997; Vilchez et al., 2009). The results of Vilchez et al.
Abbreviations: CF, colonization factor; ESBL, extended-spectrum b-
lactamase; ETEC, enterotoxigenic Escherichia coli; LT, heat-labile toxin;
ST, heat-stable toxin.
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(2009) suggest that ETEC as the only pathogen is
associated with 11.5 % (44/381) of all diarrhoea cases
investigated.
ETEC disease follows the ingestion of contaminated water or
food; the resulting watery diarrhoea can last for several days
and may result in dehydration and malnutrition in children.
This pathotype is thought to cause disease by attaching to the
small intestinal epithelium with hair-like fimbriae, and then
producing toxins that induce watery diarrhoea. Over 25
specific antigens, called colonization factors (CFs), have been
identified in strains isolated from humans (Isidean, et al.,
2011). However, in the literature, there are a significant
number of reports where ETEC strains are negative for these
antigens, suggesting the presence of additional adhesins in
clinical ETEC isolates; for example, Del Canto et al. (2012)
described the identification of a novel adhesion CS23 in the
ETEC strain 1766a. In addition, two enterotoxins have been
identified in ETEC infections, heat-labile toxins (LTs) and
heat-stable (ST) variants (STh and STp). ST variants bind to
guanylylcyclase, causing an increase in intracellular GMP
levels in the enterocyte. LT, a protein sharing many features
with cholera toxin, binds to intracellular adenylcyclase,
leading to an increase in cyclic AMP levels. The diagnosis of
ETEC infection requires the detection of one or both of these
two toxins (Kaper et al., 2004).
The development of ETEC vaccines is based on the
acquisition of natural immunity to ETEC. As the LT
enterotoxin and CFs have been shown to be immunogenic
(Steinsland et al., 2003), most vaccine candidates to date
have included these antigens. However, the most recent data
by Kotloff et al. (2013) highlighted the importance of ST
ETEC strains, as their results from a Global Enteric
Multicenter Study suggested that these ETEC variants are
within the five pathogens that should be addressed in
interventions to reduce the global burden of diarrhoea.
Nevertheless, in order to develop an effective ETEC vaccine,
the characterization of these antigens in different endemic
countries is necessary. In addition to varying global regions,
the characterization of ETEC isolates from different settings,
such as hospitals, primary care clinics and the community,
will best reflect the full spectrum of ETEC disease. Moreover,
an insight into antimicrobial resistance patterns in different
countries is important for controlling the spread of
antibiotic-resistant diarrhoeagenic bacteria.
The aims of this study were to identify the CFs and
enterotoxins present among ETEC isolated from Nicaraguan
children in hospital, primary care clinics and the commun-
ity, and to investigate the antimicrobial resistance patterns of
these ETEC strains. These findings may help with the
development of an effective ETEC vaccine and guide the
clinical management of ETEC.
METHODS
Setting. Nicaragua is a lower-to-middle income nation in Central
America. Despite improvements in child mortality in Nicaragua in
recent decades, diarrhoea continues to be among the most common
causes of child mortality (Nicaraguan Ministry of Health, 2012; Pan
American Health Organization, 2007). The current study was
conducted in León, Nicaragua’s second largest city in the Pacific
region of the country.
Sample collection. The 58 ETEC isolates analysed in this study from
children with diarrhoea under the age of 60 months were recovered
from two different studies. The first was a surveillance study of 381
children with diarrhoeal episodes, from the regional public hospital
and four public primary care clinics, between March 2005 and
September 2006 (Vilchez et al. 2009). From this study, we inves-
tigated 13 ETEC from children hospitalized for diarrhoea with severe
dehydration, and 22 strains from children evaluated for diarrhoea in a
primary care clinic. The second study was a population-based cohort
of children selected from the Health and Demographic Surveillance
Site, León (Peña, et al., 2008; Becker-Dreps, et al., 2013), who were
followed in their households for diarrhoea episodes between January
2010 and January 2011. From this community cohort, 339 stool
samples were screened from 222 children with diarrhoea. Here, we
present the analysis of 23 ETEC isolates.
Case definition. Diarrhoea in the above-mentioned studies was
defined as three or more loose, liquid or watery stools within a 24 h
period. Clinical and demographic information was obtained from the
children’s medical records (hospital and primary care clinics only)
and from questionnaires (community cohort). The severity of
diarrhoea episodes in children at the hospital and primary care
settings were defined as: 1, mild, without vomiting and with good
toleration of oral rehydration therapy at home; 2, moderate, with
fever and/or vomiting and with toleration of oral rehydration at a
health facility; and 3, severe, an episode with fever and vomiting,
requiring intravenous rehydration and hospitalization (World Health
Organization, 2000). Whilst children in the community cohort were
not examined by a clinician for dehydration levels, basic clinical data
were collected using questionnaires, such as the frequency of stools
and the presence of vomiting, fever or bloody stools. The studies were
approved by the Institutional Review Boards of the National
Autonomous University of Nicaragua, León (UNAN-León) and the
University of North Carolina at Chapel Hill, NC, USA.
Laboratory analysis. ETEC strains were cultured on MacConkey
agar with overnight incubation at 37 uC. All ETEC-positive isolates
were reanalysed by PCR as described by Vilchez et al. (2009) for the
detection of the virulence markers for the enterotoxins LT and STh,
and by Rodas et al. (2009) for enterotoxin STp, to confirm their ETEC
status prior to CF analyses.
Identification of CFs. A PCR assay for the CFs CS1, CS2, CS3, CS4,
CS5, CS6, CS7, CS8, CS12, CS13, CS14, CS15, CS18, CS20, CS21, CS22,
CFA/I, CS17 and CS19 was performed as described by Rodas et al.
(2009), with some modifications. Additionally, to confirm the PCR
analysis, some of the amplicons were analysed by sequencing the forward
and reverse strands, and parallel PCR assays for CS17 and CS19 were
performed using primers described by Del Canto et al. (2011). A 25 ml
reaction mixture with pureTaq Ready-To-Go PCR Beads (GE
Healthcare) was organized in four panels of reactions. Each reaction
mixture contained 2 ml bacterial lysate (obtained from a homogenized
suspension of bacteria adjusted to a density of a MacFarland 4 standard),
from an ETEC-positive strain or an ETEC reference strain (ETEC
091207, ETEC ATCC 35401 or E. coli ATCC 11775), 10 mM Tris/HCl
(pH 9.0), 50 mM KCl, 1.5 mM MgCl2, 200 mM each dNTP, 2.5 U
pureTaq DNA polymerase (GE Healthcare) and 0.2 mM each primer.
PCR was performed in a GeneAmp PCR system 9700 (Applied
Biosystems) with the following thermocycling conditions: 96 uC for
4 min; 35 cycles of 94 uC for 30 s, 58 uC for 30 s and 72 uC for 1 min;
and a final 7 min extension at 72 uC. PCR products (10 ml) were
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evaluated on a 2.0 % (w/v) agarose gel at 120 mV for 45 min. The
DNA bands were visualized and photographed under UV light after
staining with ethidium bromide. Each result from the multiplex-PCR
was also tested independently by PCR with a primer specific for a
suspected CF.
Antibiotic susceptibility testing. The E. coli isolates were
phenotypically screened for antibiotic resistance to ampicillin,
trimethoprim-sulfamethoxazole, ceftazidime, ceftriaxone, ciproflox-
acin, chloramphenicol, gentamicin and imipenem by a disk diffusion
test. Extended-spectrum b-lactamase (ESBL) production was con-
firmed using a disk diffusion test with the following antibiotics:
amoxicillin-clavulanic acid, ceftazidime, cefotaxime and cefepime.
Laboratory protocols used were consistent with the Clinical
Laboratory and Standards Institute guidelines (CLSI, 2012).
Data analysis. The frequency of the type of enterotoxin (STh and/or
LT) and CFs detected was calculated and compared among the
different settings of specimen collection (hospital, primary care clinics
and the community) and different age groups using Chi-squared or
Fisher’s exact test where applicable.
RESULTS
Characteristics of participants
ETEC-positive stool samples were provided by 58 children
with diarrhoea. Thirteen were obtained from the hospital,
22 from the primary care clinics and 23 from the
community cohort. The mean ages of children providing
samples in the hospital, primary care and community
settings were 10.6, 16.4 and 27.5 months, respectively.
Clinical characteristics of ETEC
The values for the mean number of stools within a 24 h
period and the incidence of breastfeeding, vomiting and
fever were 6.1, 46.2 %, 69.2 % and 53.8 % in the hospital;
4.8, 63.6 %, 22.7 % and 18.2 % in the primary care clinics;
and 4.0, 34.8 %, 21.7 % and 34.8 % in the community. All
13 children with ETEC in the hospital were characterized as
severe. Among the 22 with ETEC in the primary care
setting, 90.9 % (20/22) were characterized as mild and
9.1 % (2/22) were moderate. Among the 23 children with
ETEC at the community level, 82.6 % (19/23) were mild
and 17.4 % (4/23) were moderate.
Identification of ETEC CFs
Overall, we detected at least one CF in 50.0 % (29/58) of
the ETEC strains investigated. CS19 was detected in all
strains in which a CF was detected, either alone or in
combination with one or more other CF (Table 1).
The distribution of CFs and enterotoxins varied by setting.
At least one CF was detected among 53.8 % of ETEC
isolates from children in the hospital and 90.9 % in the
primary care clinic, compared with 8.7 % in the commun-
ity (P50.005 for comparison of hospital vs community,
and P,0.001 for comparison of primary care vs commun-
ity.) Also, STh was more commonly detected among strains
from children in the community (47.8 %) compared with
those receiving care in a primary care clinic (0.0 %)
(P,0.001), and a combination of STh and LT was more
commonly detected among strains from children receiving
care in a primary care clinic (27.3 %) compared with those
in the community (0.0 %) (P50.009). Whilst the entero-
toxins did not vary by age group, CFs tended to be more
commonly detected in strains obtained from young
children (57.1 %) compared with those from older children
(31.3 %) (P50.078 for comparison of children 0–23
months vs children 24–59 months). Surprisingly, no
ETEC STp strains were detected.
Antibiotic resistance
Among the 58 ETEC isolates, 44.8 % were resistant to
trimethoprim-sulfamethoxazole and 24.1 % were resistant
to ampicillin. Only one ETEC isolate was shown to pro-
duce ESBL.
DISCUSSION
Using a PCR-based method on ETEC isolates collected
from children with diarrhoea in hospital, primary care and
community settings, we found that 50.0 % of investigated
isolates were positive for at least one of the CFs tested, with
CS19 the most commonly identified. CFs were detected
more commonly in ETEC isolates from diarrhoea cases
treated in health facilities and from young children
compared with those from the community and from older
children, which were generally mild. Understanding the
types and distribution of CFs in various settings and age
groups is important because of their promise as ETEC
vaccine antigens, based on evidence from several epidemio-
logical, immunological and challenge studies (Sommerfelt
et al., 1996; Vidal et al., 2009). To our knowledge, this is the
second Central American report describing ETEC strains
characterization in terms of CF detection from the same
geographical site in Nicaragua.
Our findings of CF detection from health facilities are
comparable to other studies, reporting frequencies between
23 and 94 % (Isidean et al., 2011; Girón et al., 1995). In
addition, using PCR-based methods, Rodas et al. (2011)
detected at least one CF among 65 % of ETEC strains
isolated from Bolivian children hospitalized for diarrhoea.
Using mAb detection for CFs in Bangladesh, Qadri et al.
(2007) found that 56 % of ETEC strains from the hospital
setting were positive for a CF. However, we detected a
lower prevalence of CFs among ETEC strains from the
community compared with two other prior studies based
in the community (Vidal et al., 2009; Paniagua et al., 1997).
It is worth noting the findings by Del Canto et al. (2011),
where CS21 was detected in 71.8 % of ETEC strains isolated
in children from Chile, either alone or in combination with
others, and as a common factor, as in the present study for
CS19. CS19 was the most common CF detected, either
CS19 in ETEC strains from Nicaraguan children
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Table 1. Characterization of ETEC isolates from Nicaraguan children with diarrhoea
Isolates Sample origin Clinical severity Age (months) Enterotoxin CF
1 Hospital Severe 1 LT
2 Hospital Severe 3 LT CS19
3 Hospital Severe 4 LT-STh
4 Hospital Severe 7 LT
5 Hospital Severe 8 LT CS19
6 Hospital Severe 10 LT
7 Hospital Severe 10 LT CS19
8 Hospital Severe 11 LT
9 Hospital Severe 12 LT CS19
10 Hospital Severe 13 LT CS19
11 Hospital Severe 17 STh
12 Hospital Severe 21 LT CS19
13 Hospital Severe 21 LT CS19
14 Primary care Mild 1 LT CS19
15 Primary care Mild 4 LT CS19
16 Primary care Mild 4 LT CS19
17 Primary care Mild 5 LT CS19
18 Primary care Mild 7 LT CS19
19 Primary care Mild 7 LT CS19
20 Primary care Mild 10 LT CS19
21 Primary care Mild 10 LT
22 Primary care Mild 11 LT CS19
23 Primary care Mild 12 LT CS19 and CS6
24 Primary care Mild 13 LT CS19
25 Primary care Mild 13 LT-STh CS19, CS2 and CS21
26 Primary care Mild 15 LT CS19
27 Primary care Mild 16 LT-STh CS19, CS21 and CFA/I
28 Primary care Mild 16 LT
29 Primary care Mild 17 LT-STh CS19
30 Primary care Mild 17 LT-STh CS19 and CS1
31 Primary care Mild 27 LT CS19 and CFA/I
32 Primary care Mild 35 LT CS19
33 Primary care Mild 53 LT-STh CS19
34 Primary care Moderate 19 LT CS19
35 Primary care Moderate 48 LT-STh CS19
36 Community Mild 7 LT
37 Community Mild 7 STh
38 Community Mild 9 STh
39 Community Mild 13 LT
40 Community Mild 16 LT
41 Community Mild 16 LT
42 Community Mild 16 STh
43 Community Mild 17 STh CS19
44 Community Mild 18 STh
45 Community Mild 23 LT
46 Community Mild 29 LT
47 Community Mild 34 STh
48 Community Mild 34 LT
49 Community Mild 35 STh
50 Community Mild 36 LT
51 Community Mild 40 LT
52 Community Mild 42 LT
53 Community Mild 46 STh
54 Community Mild 51 LT
55 Community Moderate 15 LT
56 Community Moderate 26 STh
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alone or in combination with one or more other CFs. CS19
is a member of the class 5 fimbrial family, which includes
CS1, CS2, CS4, CS14, CS17, CS19, PCFO71 and CFA/I
(family archeotype) (Anantha et al., 2004). The earlier
study in Nicaragua by Paniagua et al. (1997) found that
36.4 % of the ETEC strains were positive for CFA/I.
In Bolivia, Rodas et al. (2011) found the following CF
frequencies: CFA/I, 18.6 %; CS17, 18.6 %; CS1+CS3, 6.9 %;
CS2+CS3, 6.9 %; CS12, 6.9 %; and CS7, 4.7 %. Thus, in
these studies and the present study, the class 5 family of
fimbriae is important among strains from Latin America and
would be important to include in an ETEC vaccine
candidate. This is supported by evidence of cross-protection
between different homologous CFs; for example, in a study of
Bangladeshi children with symptomatic or asymptomatic
infections by CFA/I, CS1+CS3, CS2+CS3 or CS5+CS6
strains, a repeat episode of diarrhoea or infection by the
homologous CF type was uncommon (Qadri et al., 2007).
Finally, our study provides evidence of antibiotic resistance
among ETEC strains. Generally, the use of antibiotics for
the treatment of diarrhoea in areas where ETEC is endemic
is not recommended due to the lack of routine diagnosis
of ETEC (Qadri et al., 2005). However, if antimicrobial
therapy is given, it should be guided by the local
susceptibility patterns of the pathogens. In spite of this, a
publication by den Engelsen et al. (2009) showed that
outpatients with diarrhoea of presumed bacterial origin at
the emergency department of the University Hospital of
León, Nicaragua, received antibiotics such as trimetho-
prim-sulfamethoxazole to shorten the course of the disease.
In our study, 44.8 % of ETEC strains were resistant to
trimethoprim-sulfamethoxazole and 24.1 % were resistant
to ampicillin. Therefore, the ETEC strains in León show
resistance to the most commonly used antibiotics, which
are on the national formulary and are readily available in
most pharmacies. In contrast, we found little resistance to
chloramphenicol, gentamicin, ciprofloxacin, ceftazidime
and ceftriaxone (,12 %), yet the production of ESBL was
confirmed in the ETEC strains resistant to ceftazidime
and ceftriaxone. In comparison, among 43 ETEC strains
isolated from hospitalized children with diarrhoea in
Bolivia, higher resistance to ampicillin (53.5 %) and
chloramphenicol (14.0 %), and lower resistance to tri-
methoprim-sulfamethoxazole (32.5 %), was found (Rodas
et al., 2011). An ETEC vaccine that effectively reduces cases
of ETEC diarrhoea may reduce the need for antibiotics and
prevent the spread of antibiotic resistance.
One strength of this study is that we detected CFs in a
variety of ETEC isolates collected from children with
diarrhoea from different settings. However, limitations of
the study are that we only studied one region and only
58 strains were analysed. Also, we cannot rule out the
possibility that the difference in CF prevalence observed in
the various settings could reflect unidentified CFs such as
the non-classical adhesins and the newly described CS23
(Del Canto et al., 2012) that our PCR-based methods did
not detect, or differences in CF distribution in the years
studied.
Our results suggest that an ETEC vaccine that includes
CFA/I in part would afford the most protection against
future infections with homologous CF-expressing ETEC
strains in León, Nicaragua. This could be particularly
beneficial in preventing more severe cases of ETEC
diarrhoea requiring health facility visits and cases among
young children.
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